Wednesday, April 11, 2012

New HIV Treatment Guidelines & Other Updates Ending the Epidemic by Paul Kawata











New HIV Treatment Guidelines & Other Updates
Ending the Epidemic by Paul Kawata

I am not usually an overly cautious man -- just look at the way I dress! However, the revised HIV Treatment Guidelines from the Department of Health and Human Services have given me pause. I find myself both cautiously optimistic, and honestly have some concerns.

Cautiously Optimistic

The new guidelines recommend that all HIV positive Americans start Antiretroviral (ARV) therapy soon after diagnosis. Previously, ARVs were recommended for People Living with HIV (PLWH) whose CD4 counts fell below 500.

While the ultimate decision about when to start treatment remains in the hands of the individual and his or her doctor, the new guidelines make the panel's recommendation about when to start treatment very clear. No longer are we dependent on CD4 counts that can fluctuate. In some ways, it may eliminate HIV-related health disparities and may result in more health care professionals feeling confident about their ability to treat PLWH.

Honest Concerns

The new guidelines did not wait for the results of the Strategies for Management of Anti-Retroviral Therapy (SMART) study. This study was supposed to determine the best time to start therapy. Treatment as Prevention (TasP) is an essential component of our efforts to end the HIV/AIDS epidemic; however, without the science of the SMART study, I am concerned that the guidelines were changed because of the excitement around TasP's potential without waiting for the results from this study.

While it's not the function of the panel, I am also concerned about our ability to pay for treatment.

According to the Centers for Disease Control and Prevention (CDC), there are around 1.2 million Americans living with HIV, just over 941,000 of them are aware of their status. Currently just over 328,000 HIV positive Americans have an undetectable viral load. If we follow the new guidelines and just use the PLWH already identified, approximately 613,000 individuals will need to start/reassess their ARV therapy. Some of them are already on treatment, but have not achieved viral suppression because they are on suboptimal treatment. The medications alone could cost as much as $8,500,000,000 per year

Until the Patient Protection and Affordable Care Act is fully implemented, enrolling this many new individuals onto treatment poses significant challenges. Most people who have private insurance or are enrolled in Medicaid or Medicare will get these life extending drugs. Still, others will be able to take advantage of the Pre-existing Condition Insurance Programs set up under the ACA to help individuals with chronic conditions receive care before all of the law’s provisions are implemented. However, many people who fall between these programs will need to rely on the AIDS Drug Assistance Program (ADAP). We still have a waiting list for this program and we don't know how many PLWHs were dropped from state's ADAP programs due to changes in eligibility.

While ADAP funding has increased steadily each year, support for the rest of the Ryan White Care Act (RWCA) remains relatively flat, with Part D receiving a significant cut in President Obama's 2013 budget request. Many communities do not have the capacity to expand services for an additional 613,000 consumers without significant increases in funding. Yet during these tough economic times, Congress does not seem willing to appropriate the resources necessary to cover this many new PLWH seeking ARVs even though treatment is recommended by the new guidelines.

From the beginning, the National Minority AIDS Council (NMAC) has said it would be impossible to implement TasP without the full implementation of the Patient Protection and Affordable Care Act. Our current system is at a breaking point. It cannot absorb an additional 613,000 HIV-positive Americans without additional resources.

My nightmare scenario is that the results of the SMART study show a different starting point to begin therapy. More likely, we enroll many more people onto ARVs, only to find out we don't have the funds to pay for the drugs. As a result, healthcare providers may still need to counsel PLWH on starting treatment only when they have consistent access and can remain adherent causing unnecessary stress and worry within communities that are already stressed and worried. Can you imagine means testing for the ADAP program? While we need treatment on demand for PLWH, we recommend caution as communities move forward to implement these new treatment guidelines.

Yours in the struggle,

Paul Kawata
Executive Director

About NMAC
The National Minority AIDS Council (NMAC) develops leadership in communities of color to end the HIV/AIDS epidemic. Since 1987, NMAC has advanced this mission through a variety of programs and services, including: a public policy education program, national and regional training conferences, a treatment and research program, numerous publications and a website: http://www.nmac.org/

Today, NMAC is an association of AIDS service organizations providing valuable information to community-based organizations, hospitals, clinics and other groups assisting individuals and families affected by the AIDS epidemic. NMAC's advocacy efforts are funded through private funders and donors only.
For more information, contact NMAC directly at (202) 483-NMAC (6622) or

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...

select key words

2007 National HIV Prevention Conference 2009 National LGBTI Health Summit 2011 LGBTI Health Summit 2012 Gay Men's Health Summit 2012 International AIDS Conference ACT Up AIDS AIDS Foundation of Chicago Africa BUTT Bisexual Bisexual Health Summit Brian Mustanski Center on Halsted Charles Stephens Chicago Chicago Black Gay Men's Caucus Chicago Task Force on LGBT Substance Use and Abuse Chris Bartlett Coaching with Jake Congress David Halperin David Munar Dr. James Holsinger Dr. Jesus Ramirez-Valles Dr. Rafael Diaz Dr. Ron Stall ENDA Ed Negron Eric Rofes FTM Feast of Fun Feel the love... Friday is for Faeries Gay Men's Health Summit 2010 HCV HIV HIV care HIV drugs HIV negative HIV positive HIV prevention HIV stigma HIV strategic plan HIV testing HIV/AIDS HPV Howard Brown Health Center IML IRMA Illinois International AIDS Conference Jim Pickett LGBT LGBT adoption LGBT culture LGBT health LGBT rights LGBT seniors LGBT youth LGBTI community LGBTI culture LGBTI health LGBTI rights LGBTI spirituality LGV Leon Liberman LifeLube LifeLube forum LifeLube poll LifeLube subscription Lorenzo Herrera y Lozano Lymphogranuloma Venereum MRSA MSM Monday Morning Perk-Up National AIDS Strategy National Gay Men's Health Summit One Fey's Tale Peter Pointers Pistol Pete PnP PrEP President Barack Obama Presidential Campaign Project CRYSP Radical Faerie STD Senator Barack Obama Sister Glo Sisters of Perpetual Indulgence Susan Kingston Swiss declaration Ted Kerr Test Positive Aware Network The "Work-In" The 2009 Gay Men's Health Agenda Tony Valenzuela Trans Gynecology Access Program Trans and Intersex Association Trevor Hoppe Who's That Queer Woof Wednesday You Tube abstinence only activism advocacy african-american aging issues anal cancer anal carcinoma anal health anal sex andrew's anus athlete ball scene bareback porn barebacking bathhouses bears big bold and beautiful bisexuality black gay men black msm blood ban blood donor body image bottom chubby chaser circumcision civil rights civil union communication community organizing condoms crystal meth dating dating and mating with alan irgang depression disclosure discrimination domestic violence don't ask don't tell douche downlow drag queen emotional health exercise female condom fitness gay culture gay identity gay latino gay male sex gay marriage gay men gay men of color gay men's health gay pride gay rights gay rugby gay sex gay youth gender harm reduction hate crime health care health care reform health insurance hepatitis C hiv vaccine homophobia homosexuality hottie hotties how are you healthy? human rights humor hunk immigration international mr. leather internet intimacy leather community leathersex lifelube survey love lube lubricant masturbation mental health microbicides middle music negotiated safety nutrition oral sex physical health pleasure podcast policy politics poppers porn post-exposure prophylaxis prevention prostate prostate cancer public health public sex venues queer identity racism recovery rectal microbicides relationships religion research safe sex semen sero-adaptation sero-sorting seroguessing sex sexual abuse sexual addiction sexual health sexual orientation smoking social marketing spirituality stigma stonewall riots substance abuse treatment substance use suicide super-bug superinfection syphilis testicle self-examination testicular cancer testing top trans group blog transgender transgender day of remembrance transgendered transmen transphobia transsexual universal health care unsafe sex vaccines video violence viral load writers yoga youtube